Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Cobas Roberta"'
Autor:
Nogueira, Jeane de Souza, Gomes, Thamires Rodrigues, Secco, Danielle Angst, de Almeida, Inez Silva, da Costa, Alessandra Saldanha Matheus Fernandes, Cobas, Roberta Arnoldi, Costa dos Santos, Gilson, Jr, Gomes, Marília Brito, Porto, Luís Cristóvão
Publikováno v:
In Immunology Letters June 2024 267
Autor:
Giuffrida Fernando MA, Guedes Alexis D, Rocco Eloa R, Mory Denise B, Dualib Patricia, Matos Odelisa S, Chaves-Fonseca Reine M, Cobas Roberta A, Negrato Carlos Antonio, Gomes Marilia B, Dib Sergio A
Publikováno v:
Cardiovascular Diabetology, Vol 11, Iss 1, p 156 (2012)
Abstract Background Cardiovascular risk factors (CVRF) may cluster in type 1 diabetes, analogously to the metabolic syndrome described in type 2 diabetes. The threshold of HbA1c above which lipid variables start changing behavior is unclear. This stu
Externí odkaz:
https://doaj.org/article/2dfced5f61424200a1b91581f4a4ed02
Autor:
Gomes Marília B, Cobas Roberta A, Matheus Alessandra S, Tannus Lucianne R, Negrato Carlos, Rodacki Melanie, Braga Neuza, Cordeiro Marilena M, Luescher Jorge L, Berardo Renata S, Nery Marcia, Marques MariadoCarmo A, Calliari Luiz E, Noronha Renata M, Manna Thais D, Zajdenverg Lenita, Salvodelli Roberta, Penha Fernanda G, Foss Milton C, Foss-Freitas Maria C, Pires Antonio C, Robles Fernando C, Guedes MariadeFátimaS, Dib Sergio A, Dualib Patricia, Silva Saulo C, Sepulvida Janice, Almeida Henriqueta G, Sampaio Emerson, Rea Rosangela, Faria Ana Cristina R, Tschiedel Balduino, Lavigne Suzana, Cardozo Gustavo A, Azevedo Mirela J, Canani Luis, Zucatti Alessandra T, Coral Marisa Helena C, Pereira Daniela, Araujo Luiz, Tolentino Monica, Pedrosa Hermelinda C, Prado Flaviane A, Rassi Nelson, Araujo Leticia B, Fonseca Reine Marie C, Guedes Alexis D, Matos Odelissa S, Faria Manuel, Azulay Rossana, Forti Adriana C, Façanha Cristina, Montenegro Ana, Montenegro Renan, Melo Naira H, Rezende Karla F, Ramos Alberto, Felicio João, Santos Flavia M, Jezini Deborah L
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 4, Iss 1, p 44 (2012)
Abstract Background To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovas
Externí odkaz:
https://doaj.org/article/e7ce7ed5ac2c49a0887bc1e80e5633de
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 3, Iss 1, p 21 (2011)
Abstract Background The presence of microalbuminuria can be associated with overt nephropathy and cardiovascular disease in patients with type 1 diabetes (T1D). We aimed to determine the incidence and evaluate the baseline predictors for the developm
Externí odkaz:
https://doaj.org/article/e125b8e87be04c62b85c7a07f46398bf
Autor:
Dias Viviane M, Pandini Juliana A, Nunes Raquel R, Sperandei Sandro LM, Portella Emilson S, Cobas Roberta A, Gomes Marília de B
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 54 (2010)
Abstract Background The importance of achieving and maintaining an appropriate metabolic control in patients with type 1 diabetes mellitus (DM1) has been established in many studies aiming to prevent the development of chronic complications. The carb
Externí odkaz:
https://doaj.org/article/92294f667e754cc68b91406a51bc074f
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 57 (2010)
Externí odkaz:
https://doaj.org/article/987c4845392f47c68f40fcde6690329a
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 16 (2010)
Abstract Aims To determine prospectively the efficacy, tolerability and patient satisfaction of an extended release formulation of metformin (metformin XR) in hospital based outpatients with type 2 diabetes mellitus currently treated with standard me
Externí odkaz:
https://doaj.org/article/17fd9ab1d5f84eea85175e8b5dcb67c6
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 4 (2010)
Abstract Background Angiotensin-converting enzyme (ACE) inhibitors are widely prescribed for patients with diabetes as a nephroprotector drug or to treat hypertension. Generally they are safe for clinical practice, but the relationship between these
Externí odkaz:
https://doaj.org/article/b1f9b0b39d1a401bb60160889be25bed
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 10 (2010)
Abstract Background Diabetes is considered an independent risk factor for cognitive impairment and some studies observed through neuropsychological tests that cognitive disfunction affects both elderly and younger patients with diabetes. The aims of
Externí odkaz:
https://doaj.org/article/dbc051ab01614155bae757bc1d6a9919
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 1, Iss 1, p 24 (2009)
Abstract The present study was designed to study skin capillary density and recruitment of the upper and lower extremities in patients with type 1 diabetes with vascular complications, when compared to patients without complications and healthy subje
Externí odkaz:
https://doaj.org/article/b3a391fd696043549f467d64dec73583